FDAFDA · Food and drugs·Recall number D-0003-2023
Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)
Published October 12, 2022 · Recall initiated: September 27, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- AMINOPHYLLINE
- Manufacturer
- Pfizer Inc.
- Distributor
- Distributed in the United States and Puerto Rico.
- Lot
- Lot: 30-137-DK Exp. 1 DEC. 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.